Animal models for medications screening to treat addiction / Edited by Richard L. Bell, Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, IN, United States, Shafiqur Rahman, Department of Pharmaceutical Sciences, South Dakota State University, Brookings, SD, United States.

Includes bibliographical references and index.

Considerations in the evaluation of potential efficacy of medications for alcohol and drug use disorders: an editorial -- A pressing need for pharmacotherapy development to treat drug addiction: an editorial from a legal perspective -- Identification of treatment targets in a genetic mouse model of voluntary methamphetamine drinking -- Screening medications for the treatment of cannabis use disorder -- How can we improve on modeling nicotine addiction to develop better smoking cessation treatments? -- An animal model of alcohol dependence to screen medications for treating alcoholism -- A genetic animal model of alcoholism for screening medications to treat addiction -- Animal models and the development of vaccines to treat substance use disorders -- Genes and alcohol studies with mutant mice -- Gene targeting studies of hyperexcitability and affective states of alcohol withdrawl in rodents -- Abstinence-conflict model: toward an optimal animal model for screening medications promoting drug abstinence -- Prarie voles as a model to screen medications for the treatment of alcoholism and addictions -- Animal models for medication development and application to treat fetal alcohol effects -- Using in vitro electrophysiology to screen medications: accumbal plasticity as an engram of alcohol dependence -- The zebrafish, a novel model organism for screening compounds affecting acute and chronic ethanol-induced effects.